YM BioSciences (YMI) Prices 35M Offering at $2/Share
Tweet
Share
E-mailGet Alerts YMI Hot Sheet
Join SI Premium – FREE
YM BioSciences Inc. (AMEX: YMI) announced the pricing of 35,000,000 common shares at US$2.00 per common share in its previously announced underwritten public offering.
BofA Merrill Lynch is acting as sole book-running manager for the Offering and Wells Fargo Securities, LLC is acting as lead manager. JMP Securities LLC, Collin Stewart LLC, Rodman & Renshaw, LLC and Roth Capital Partners, LLC are acting as co-managers for the Offering. In addition, the Company granted to the underwriters a 30-day option to purchase an additional 5,250,000 common shares. The offering is expected to close on or about February 29, 2012, subject to customary closing conditions.
BofA Merrill Lynch is acting as sole book-running manager for the Offering and Wells Fargo Securities, LLC is acting as lead manager. JMP Securities LLC, Collin Stewart LLC, Rodman & Renshaw, LLC and Roth Capital Partners, LLC are acting as co-managers for the Offering. In addition, the Company granted to the underwriters a 30-day option to purchase an additional 5,250,000 common shares. The offering is expected to close on or about February 29, 2012, subject to customary closing conditions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- Curvature Securities terminates ATM sales pact with Planet Green
- ZeroStack (ZSTK) files for 54.61M share offering by selling stockholders
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Roth Capital, JMP Securities, Rodman & Renshaw, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
